Original Research

Published on 08 Nov 2024

Seroprevalence of anti-SARS-CoV-2 IgM and IgG and COVID-19 vaccine uptake in healthy volunteers in Nairobi, Kenya: a cross-sectional study

in Virus and Host Immunity

Agnes Muhonja Otindo
Eric M. Ndombi
Martin Theuri
Margaret Muturi
Peris Thamaini
James Ogutu
Lister Onsongo
June K. Madete
Victor Ofula
Samuel Gitau

Frontiers in Virology

doi 10.3389/fviro.2024.1479645

439 views

Review

Published on 28 Oct 2024

Human cellular restriction factors that target SARS-CoV-2 replication

in Virus and Host Immunity

Amukelani Marivate
Shani Bekker
Muhammad Qasim Fish
Salerwe Mosebi

Frontiers in Virology

doi 10.3389/fviro.2024.1462283

579 views

Original Research

Published on 18 Oct 2024

Klebsiella pneumoniae co-infection leads to fatal pneumonia in SARS-CoV-2-infected mice

in Virus and Host Immunity

Crystal Villalva
Girish Patil
Sai Sankara Narayanan
Roshan Ghimire
Debarati Chanda
Nishantha Samarakoon
Timothy Snider
Akhilesh Ramachandran
Rudragouda Channappanavar
Sunil More

Frontiers in Virology

doi 10.3389/fviro.2024.1426728

538 views

Original Research

Published on 06 Aug 2024

Severe acute respiratory syndrome coronavirus-2 seroprevalence in non-vaccinated people living with HIV in Uganda during 2022

in Virus and Host Immunity

Provia Ainembabazi
Letisha Najjemba
Joseph Musaazi
Mario Hönemann
Barbara Castelnuovo
Amrei von Braun

Frontiers in Virology

doi 10.3389/fviro.2024.1429785

880 views

Mini Review

Published on 01 May 2024

Wielding a double-edged sword: viruses exploit host DNA repair systems to facilitate replication while bypassing immune activation

in Virus and Host Immunity

Nicholas Saladino
Daniel J. Salamango

Frontiers in Virology

doi 10.3389/fviro.2024.1410258

1,307 views
1 citation

Mini Review

Published on 06 Mar 2024

DNA methylation in long COVID

in Virus and Host Immunity

Yangfan Xiao
Sten H. Vermund

Frontiers in Virology

doi 10.3389/fviro.2024.1371683

2,734 views
1 citation

Original Research

Published on 24 Jan 2024

APOBEC3D excludes APOBEC3F from HIV-1 virions by competitive binding of RNA

in Virus and Host Immunity

Shreoshri Bhattacharjee
Amit Gaba
Linda Chelico

Frontiers in Virology

doi 10.3389/fviro.2024.1343037

1,120 views

Review

Published on 18 Dec 2023

APOBEC3 family proteins as drivers of virus evolution

in Virus and Host Immunity

Michael Jonathan
Terumasa Ikeda

Frontiers in Virology

doi 10.3389/fviro.2023.1332010

2,083 views
2 citations

Review

Published on 13 Nov 2023

Beyond survival: unraveling the dynamics of Ebola virus resurgence in Sub-Saharan Africa and the remarkable journey of survivors

in Virus and Host Immunity

Eric Asare Fenteng
Paul Poku Sampene Ossei
William Gilbert Ayibor
Tracy Narh-Bedu

Frontiers in Virology

doi 10.3389/fviro.2023.1227314

3,036 views

Original Research

Published on 27 Jun 2023

Chronic HCV infection promotes cytotoxicity in antigen-specific CD8+ T cells regardless of virus specificity

in Virus and Host Immunity

Ana C. Maretti-Mira
Matthew P. Salomon
Angela M. Hsu
Chikako Matsuba
Lucy Golden-Mason

Frontiers in Virology

doi 10.3389/fviro.2023.1198361

3,782 views
1 citation

Original Research

Published on 02 Jun 2023

Antiviral treatment with valacyclovir reduces virus shedding in saliva of Antarctic expeditioners

in Virus and Host Immunity

Satish K. Mehta
Douglass M. Diak
Bridgette V. Rooney
Stephanie S. Krieger
Mayra Nelman-Gonzalez
James P. Locke
Maria A. Nagel
Millennia Young
Brian E. Crucian

Frontiers in Virology

doi 10.3389/fviro.2023.1157659

7,291 views
1 citation

Review

Published on 06 Mar 2023

Malignancy and viral infections in Sub-Saharan Africa: A review

in Virus and Host Immunity

Mahamadou Diakite
Kathryn Shaw-Saliba
Chuen-Yen Lau

Frontiers in Virology

doi 10.3389/fviro.2023.1103737

8,912 views
5 citations

Original Research

Published on 03 Mar 2023

Epitope mapping of SARS-CoV-2 spike protein differentiates the antibody binding activity in vaccinated and infected individuals

in Virus and Host Immunity

Nathaniel Felbinger
David Trudil
Lawrence Loomis
Richard Ascione
Gregory Siragusa
Seiji Haba
Shruti Rastogi
Aidan Mucci
Mark Claycomb
Sebastian Snowberger

Frontiers in Virology

doi 10.3389/fviro.2023.988109

2,509 views
1 citation

Original Research

Published on 01 Mar 2023

Frequent use of IGHV3-30-3 in SARS-CoV-2 neutralizing antibody responses

in Virus and Host Immunity

Pradeepa Pushparaj
Andrea Nicoletto
Xaquin Castro Dopico
Daniel J. Sheward
Sungyong Kim
Simon Ekström
Ben Murrell
Martin Corcoran
Gunilla B. Karlsson Hedestam

Frontiers in Virology

doi 10.3389/fviro.2023.1128253

2,740 views
1 citation

Original Research

Published on 10 Jan 2023

CD4+ T lymphocyte recovery in the modern antiretroviral therapy era: Toward a new threshold for defining immunological non-responders

in Virus and Host Immunity

Lucia Taramasso
Laura Labate
Federica Briano
Giorgia Brucci
Sara Mora
Sabrina Blanchi
Mauro Giacomini
Matteo Bassetti
Antonio Di Biagio

Frontiers in Virology

doi 10.3389/fviro.2022.822153

1,632 views
2 citations

Review

Published on 28 Nov 2022

Overview of how HCMV manipulation of host cell intracellular trafficking networks can promote productive infection

in Virus and Host Immunity

Bailey S. Mosher
Timothy F. Kowalik
Andrew D. Yurochko

Frontiers in Virology

doi 10.3389/fviro.2022.1026452

2,087 views
1 citation

Navigation group

Articles

Seroprevalence of anti-SARS-CoV-2 IgM and IgG and COVID-19 vaccine uptake in healthy volunteers in Nairobi, Kenya: a cross-sectional study

Human cellular restriction factors that target SARS-CoV-2 replication

Klebsiella pneumoniae co-infection leads to fatal pneumonia in SARS-CoV-2-infected mice

Severe acute respiratory syndrome coronavirus-2 seroprevalence in non-vaccinated people living with HIV in Uganda during 2022

Wielding a double-edged sword: viruses exploit host DNA repair systems to facilitate replication while bypassing immune activation

DNA methylation in long COVID

APOBEC3D excludes APOBEC3F from HIV-1 virions by competitive binding of RNA

APOBEC3 family proteins as drivers of virus evolution

Beyond survival: unraveling the dynamics of Ebola virus resurgence in Sub-Saharan Africa and the remarkable journey of survivors

Chronic HCV infection promotes cytotoxicity in antigen-specific CD8+ T cells regardless of virus specificity

Antiviral treatment with valacyclovir reduces virus shedding in saliva of Antarctic expeditioners

Malignancy and viral infections in Sub-Saharan Africa: A review

Epitope mapping of SARS-CoV-2 spike protein differentiates the antibody binding activity in vaccinated and infected individuals

Frequent use of IGHV3-30-3 in SARS-CoV-2 neutralizing antibody responses

CD4+ T lymphocyte recovery in the modern antiretroviral therapy era: Toward a new threshold for defining immunological non-responders

Overview of how HCMV manipulation of host cell intracellular trafficking networks can promote productive infection